March 2009
A Novel Microwave-Assisted Green Synthesis of Condensed 2-Substituted-pyrimidin-
4(3H)-ones Under Solvent-Free Conditions
183
on a Varian Mercury YH-300 FT NMR spectrometer in
DMSO-d6 with chemical shifts (d) given in ppm relative to
TMS as internal standard. Thin layer chromatography was per-
formed on precoated silica plates (Merck Silicagel F254) using
hexane-ethyl acetate-glacial acetic acid (4.5 mL:0.5
mL:2drops), chloroform-methanol (4.5 mL:0.5 mL) as the sol-
vent systems and the spots were visualized by exposure to
iodine vapors or under ultra violet (UV) light. The HCl used
was 33% w/v aqueous and was of LR grade.
1H, 3-NH). Anal. Calcd. for C9H8N2O: C, 67.44; H, 5.02.
Found: C, 67.63; H, 5.42.
6,7-Dimethoxy-2-methylquinazolin-4(3H)-one
compound was obtained according to the aforementioned gen-
eral procedure; IR (potassium bromide): CO 1669 cmꢁ1 1H
(3g). This
;
NMR: d 2.55 (s, 3H, 2-CH3), 3.99 (s, 6H, 6- and 7-OCH3),
7.02–7.55 (m, 2H, phenyl protons), 10.87 (s, 1H, 3-NH). Anal.
Calcd. for C11H12N2O3: C, 59.90; H, 5.41. Found: C, 58.99;
H, 5.72.
2-Methyl-3H-[1,2,4]triazino[6,1-b]quinazolin-4,10-dione (3h).
This compound was obtained according to the aforementioned
General procedure A.
Reaction of 2-amino-3-carbethoxysubstrates 2 with nitriles
(in presence of only conc. HCl). A mixture of the appropriate
2-amino-3-carbethoxy substrate 2 (0.02 moles), nitrile (0.022
moles) and catalytic amount of HCl (33% w/v, 5.0 mL) was
irradiated at 350 W for 10–75 min in a microwave synthesizer.
The progress of reaction was monitored (using TLC) after 5-
min intervals. The reaction mixture was allowed to cool to
room temperature, and after completion of the reaction poured
into ice-water. The resulting precipitated solid was collected
by filtration, washed with chilled water and dried. The crude
product on recrystallization from methanol-chloroform mixture
yielded the appropriate condensed 2-substitutedpyrimidin-4-
(3H)-ones 3a–h, 4b, 4d–f, and 5a–h.
2-Methyl-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyri-
midin-4-one (3a). This compound was obtained according to
the aforementioned general procedure; IR (potassium bro-
mide): CO 1659 cmꢁ1 1H NMR: d 1.77 (s, 4H, 6- and 7-
;
CH2), 2.30 (s, 3H, 2-CH3), 2.70 (s, 2H, 5-CH2), 2.83 (s, 2H,
8-CH2). Anal. Calcd. for C11H12N2OS: C, 59.90; H, 5.47.
Found: C, 59.66; H, 5.38.
general procedure; IR (potassium bromide): CO 1680 cmꢁ1
;
1H NMR: d 2.37 (s, 3H, 2-CH3), 7.72–8.22 (m, 4H, phenyl
protons). Anal. Calcd. for C11H8N4O2: C, 57.90; H, 3.51.
Found: C, 57.69; H, 3.71.
2-(2-Chloroethyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-
one (4b). This compound was obtained according to the afore-
mentioned general procedure; IR (potassium bromide): CO 1669
; d 2.38 (s, 3H, 5-CH3), 2.47 (s, 3H,
cmꢁ1 1H NMR:
6-CH3), 3.19 (t, 2H, 2-CH2CH2Cl, J ¼ 7.5 Hz), 3.97 (t, 2H,
2-CH2CH2Cl , J ¼ 7.2 Hz), 12.34 (s, br, 1H, 3-NH). Anal. Calcd.
for C10H11ClN2OS: C, 49.40; H, 4.53. Found: C, 49.14; H, 4.35.
Ethyl 2-(2-chloroethyl)-3,4-dihydro-5-methyl-4-oxothieno
[2,3-d]pyrimidin 6-carb-oxylate (4d). This compound was
obtained according to the aforementioned general procedure;
IR (potassium bromide): CO 1719, 1670 cmꢁ1 1H NMR: d
;
1.41 (t, 3H, 6-COOCH2CH3, J ¼ 7.3 Hz), 2.9 (s, 3H, 5-CH3),
3.24 (t, 2H, 2-CH2CH2Cl, J ¼ 6.7 Hz), 4.29 (t, 2H, 2-
CH2CH2Cl, J ¼ 7.3 Hz CH2), 4.3 (q, 2H, 6-COOCH2CH3, J
¼
7.1 Hz), 12.30 (s, 1H, 3-NH). Anal. Calcd. for
C11H13ClN2O2S: C, 47.93; H, 4.35. Found: C, 47.97; H, 4.42.
2-(2-Chloroethyl)-5-phenylthieno[2,3-d]pyrimidin-4(3H)-one
(4e). This compound was obtained according to the aforemen-
tioned general procedure; IR (potassium bromide): CO
2,5,6-Trimethylthieno[2,3-d]pyrimidin-4(3H)-one (3b). This
compound was obtained according to the aforementioned gen-
;
eral procedure; IR (potassium bromide): CO 1665 cmꢁ1 1H
NMR: d 2.37 (s, 3H, 2-CH3), 2.46 (s, 3H, 5-CH3), 2.51 (s, 3H,
6-CH3), 12.04 (s, br, 1H, 3-NH). Anal. Calcd. for C9H10N2OS:
C, 55.64; H, 5.15. Found: C, 55.81; H, 5.52.
1685cmꢁ1
;
1H NMR: d 3.19 (t, 2H, 2-CH2CH2Cl, J ¼ 7.2
Hz), 4.02 (t, 2H, 2-CH2CH2Cl, J ¼ 7.5 Hz), 7.30–7.50 (m,
6H, phenyl protons and 6-H), 12.40 (s, br, 1H, 3-NH). Anal.
Calcd. for C14H11ClN2OS: C, 57.83; H, 3.81. Found: C, 57.74;
H, 3.89.
2-Methyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidin-4(3H)-one
(3c). This compound was obtained according to the aforemen-
tioned general procedure; IR (potassium bromide): CO 1670
1
cmꢁ1; H NMR: d 2.39 (s, 3H, 2-CH3), 2.47 (s, 3H, ArACH3),
2-(2-Chloroethyl)quinazolin-4(3H)-one (4f). This compound
was obtained according to the aforementioned general proce-
;
dure; IR (potassium bromide): CO 1678 cmꢁ1 1H NMR: d
3.18 (t, 2H, 2-CH2CH2Cl, J ¼ 6.3, 7.2 Hz), 4.06 (t, 2H, 2-
CH2CH2Cl, J ¼ 6.3, 7.2 Hz), 7.44–8.07 (m, 4H, phenyl pro-
tons), 10.25 (s, 1H, 3-NH). Anal. Calcd. for C10H9ClN2O: C,
57.55; H, 4.37. Found: C, 57.49; H, 4.80.
7.04 (s, 1H, 6-H), 7.16–7.48 (m, 4H, phenyl protons), 11.90 (s,
1H, 3-NH). Anal. Calcd. for C14H14N2OS: C, 65.66; H, 4.73.
Found: C, 65.76; H, 4.52.
Ethyl 3,4-dihydro-2,5-dimethyl-4-oxothieno[2,3-d]pyrimidin
6-carboxylate (3d). This compound was obtained according to
the aforementioned general procedure; IR (potassium bro-
mide): CO 1718, 1667 cmꢁ1 1H NMR: d 1.40 (t, 3H, 6-
;
COOCH2CH3, J ¼ 7.3 Hz), 2.55 (s, 3H, 2-CH3), 2.94 (s, 3H,
5-CH3), 4.36(q, 2H, 6-COOCH2CH3, J ¼ 7.1 Hz,); 10.95 (1H,
s, 3-NH). Anal. Calcd. for C10H11N2O2S: C, 52.37; H, 4.74.
Found: C, 52.56; H, 4.97.
2-Methyl-5-phenylthieno[2,3-d]pyrimidin-4(3H)-one (3e). This
compound was obtained according to the aforementioned gen-
;
eral procedure; IR (potassium bromide): CO 1671 cmꢁ1 1H
NMR: d 3.36 (s, 3H, 2-CH3), 7.31–7.50 (m, 5H, phenyl pro-
tons and 6-H), 12.28(s, 1H, 3-NH). Anal. Calcd. for
C13H10N2OS: C, 64.46; H, 4.12. Found: C, 64.15; H, 4.46.
2-Methylquinazolin-4(3H)-one (3f). This compound was
obtained according to the aforementioned general procedure;
IR (potassium bromide): CO 1666 cmꢁ1; H NMR: d 2.50 (s,
2H, 2-CH3), 7.38–7.74 (m, 4H, phenyl protons), 12.13 (s, br,
2-Chloromethyl-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-
d]pyrimidin-4-one (5a). This compound was obtained accord-
ing to the aforementioned general procedure; IR (potassium
1
bromide): CO 1663 cmꢁ1; H NMR: d 1.86 (s, 4H, 6- and 7-
CH2), 2.79 (s, 2H, 5-CH2), 3.02 (s, 2H, 8-CH2), 4.55 (s, 2H,
2-CH2Cl), 10.65 (s, br, 1H, 3-NH). Anal. Calcd. for
C11H11ClN2OS: C, 51.87; H, 4.30. Found: C, 57.69; H, 4.25.
2-Chloromethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-
one (5b). This compound was obtained according to the afore-
mentioned general procedure; IR (potassium bromide): CO 1662
cmꢁ1 1H NMR: d 2.39 (s, 3H, 5-CH3), 2.47 (s, 3H, 6-CH3),
;
4.51 (s, 2H, 2-CH2Cl), 10.03(s, br, 1H, 3-NH). Anal. Calcd. for
C9H9ClN2OS: C, 47.20; H, 3.95. Found: C, 47.30; H, 3.40.
2-Chloromethyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidin-
4(3H)-one (5c). This compound was obtained according to the
1
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet